Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors
- PMID: 23163894
- DOI: 10.3109/00365548.2012.737930
Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors
Abstract
Objective: The aim of this study was to determine the association of the Helicobacter pylori virulence factors, cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA) antibodies, with serum levels of interleukin (IL)-12 and IL-13 in H. pylori-infected duodenal ulcer (DU) patients and H. pylori-infected asymptomatic (AS) carriers in order to elucidate any correlation between them.
Methods: A total of 67 DU patients, 48 AS individuals, and 26 healthy H. pylori-negative subjects were enrolled in this study. Serum concentrations of IL-12 and IL-13 were determined by enzyme-linked immunosorbent assay (ELISA) method. Patient sera were tested by Western blot method to determine the presence of serum antibodies to bacterial virulence antigens p120 (CagA) and p95 (VacA). Serum concentrations of IL-12 and IL-13 were compared in 9 groups, including 4 AS phenotypes (CagA⁺VacA⁺, CagA⁺VacA⁻, CagA⁻VacA⁺, CagA⁻VacA⁻), 4 DU phenotypes (CagA⁺VacA⁺, CagA⁺VacA⁻, CagA⁻VacA⁺, CagA⁻VacA⁻), and 1 control group.
Results: The results revealed that DU patients positive for CagA, independent of the anti-VacA antibody status, showed drastically elevated levels of IL-12 (251 ± 43 pg/ml) when compared with the other groups (p = 0.0001). No significant difference was found between groups regarding levels of IL-13 (p > 0.05).
Conclusions: Our findings indicate that in the DU group, the serum concentrations of IL-12 but not of IL-13 were influenced by bacterial CagA, independent of the VacA status, suggesting that high IL-12 levels may contribute to susceptibility to DU in CagA-positive individuals. These findings could possibly be considered to improve the predictive or prognostic values of inflammatory cytokines for DU, and also to design possible novel therapeutic approaches.
Similar articles
-
The association of interleukin-18 promoter polymorphisms and serum levels with duodenal ulcer, and their correlations with bacterial CagA and VacA virulence factors.Scand J Infect Dis. 2013 Aug;45(8):584-92. doi: 10.3109/00365548.2013.794301. Epub 2013 Jun 9. Scand J Infect Dis. 2013. PMID: 23746337
-
Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.Int J Clin Pract. 2006 Oct;60(10):1239-43. doi: 10.1111/j.1742-1241.2005.00778.x. Epub 2006 Mar 27. Int J Clin Pract. 2006. PMID: 16669834
-
Divergence of virulence factors of Helicobacter pylori among clinical isolates does not correlate with disease specificity.J Gastroenterol. 1999;34 Suppl 11:6-9. J Gastroenterol. 1999. PMID: 10616758
-
Helicobacter pylori: focus on CagA and VacA major virulence factors.Salud Publica Mex. 2004 Nov-Dec;46(6):538-48. doi: 10.1590/s0036-36342004000600010. Salud Publica Mex. 2004. PMID: 15624859 Review.
-
Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.World J Gastroenterol. 2014 Aug 7;20(29):9882-97. doi: 10.3748/wjg.v20.i29.9882. World J Gastroenterol. 2014. PMID: 25110419 Free PMC article. Review.
Cited by
-
Outer Membrane Vesicles (OMVs) as Biomedical Tools and Their Relevance as Immune-Modulating Agents against H. pylori Infections: Current Status and Future Prospects.Int J Mol Sci. 2023 May 10;24(10):8542. doi: 10.3390/ijms24108542. Int J Mol Sci. 2023. PMID: 37239888 Free PMC article. Review.
-
Influence of H. pylori CagA Coupled with Alcohol Consumption on Cytokine Profiles in Men.Medicine (Baltimore). 2016 Feb;95(5):e2721. doi: 10.1097/MD.0000000000002721. Medicine (Baltimore). 2016. PMID: 26844515 Free PMC article.
-
Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis.Front Microbiol. 2016 Dec 15;7:1916. doi: 10.3389/fmicb.2016.01916. eCollection 2016. Front Microbiol. 2016. PMID: 28018296 Free PMC article.
-
A review on the research progress on non-pharmacological therapy of Helicobacter pylori.Front Microbiol. 2023 Mar 17;14:1134254. doi: 10.3389/fmicb.2023.1134254. eCollection 2023. Front Microbiol. 2023. PMID: 37007498 Free PMC article. Review.
-
Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.Cells. 2020 Dec 25;10(1):27. doi: 10.3390/cells10010027. Cells. 2020. PMID: 33375694 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous